| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.406 | -19.710 | 1.427 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Income - EUR | 12.296 | 106.765 | 8.907 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 115.109 | 22.850 | 9.306 | 2.750 | 14.290 | 83 | 290 | 145 | - | - |
| Gross Profit/Loss - EUR | -102.813 | 83.915 | -399 | -2.750 | -14.290 | -83 | -290 | -145 | - | - |
| Net Profit/Loss - EUR | -102.813 | 83.915 | -797 | -2.750 | -14.290 | -83 | -290 | -145 | - | - |
| Employees | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Pharma Life Concept Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51.285 | 32.762 | 25.306 | 22.092 | 16.026 | 15.640 | 15.003 | 15.422 | - | - |
| Current Assets | 1.079.402 | 16.493 | 24.566 | 24.110 | 8.384 | 8.225 | 8.042 | 8.068 | - | - |
| Inventories | 14.630 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 1.013.084 | 16.471 | 24.481 | 24.032 | 8.380 | 8.221 | 8.039 | 8.064 | - | - |
| Cash | 51.688 | 21 | 85 | 78 | 4 | 4 | 4 | 4 | - | - |
| Shareholders Funds | -429.085 | -343.335 | -338.344 | -334.885 | -342.690 | -336.276 | -329.109 | -329.757 | - | - |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | - | - |
| Debts | 1.559.818 | 392.590 | 388.216 | 381.087 | 367.100 | 360.141 | 352.154 | 353.247 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Life Concept Srl